Operating in a fragmented market the company has developed a well-rehearsed acquisition playbook that turns companies around quickly.
The acquisitions also add numerous cross-selling opportunities and the company is gradually turning into a more sophisticated, integrated healthcare IT platform.
The shares are attractively priced although the acquisitions are mostly financed through high-yielding preferred shares, a little unconventional and the jury is still out on that.
Looking for more investing ideas like this one? Get them exclusively at SHU Growth Portfolio. Get started today »